Virtual AppLication-supported ENvironment To INcrease Exercise During Cardiac Rehabilitation Study

Cardiovascular Diseases Clinical Trial

— VALENTINE  

Official title:

Virtual AppLication-supported ENvironment To INcrease Exercise During Cardiac Rehabilitation Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04587882
• Other study ID #: HUM00162365
• Status: Completed
• Phase: N/A
• Start date: October 23, 2020
• Est. completion date: October 25, 2022

Study information

• Verified date: November 2022
• Source: University of Michigan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The researchers are trying to determine whether a smartwatch and a mobile application, which together deliver activity and goal setting notifications, can increase activity levels for patients enrolled in cardiac rehabilitation.

Description:

The VALENTINE Cardiac Rehabilitation Study will evaluate a digital intervention to supplement cardiac rehabilitation for low- and moderate risk patients, integrating a mobile application with physiologic and contextual information from wearables to provide incremental support to patients. The study will be performed in conjunction with planned home-, hybrid-, or center-based cardiac rehabilitation at Michigan Medicine. Participants will be randomized to the control or telehealth group. Both groups will receive a smartwatch and usual care. Participants in the telehealth arm will additionally (1) have access to activity tracking and goal setting through the VALENTINE app; (2) receive micro-randomized, contextually tailored notifications, and (3) receive weekly activity summaries via email, which will also be provided to their exercise physiologist while enrolled in cardiac rehabilitation. Contextually tailored notifications will be one of two types: walking and exercise notifications. Walking notifications are designed to encourage participants to be active though at lower than their target heart rate zone. Participants will receive 1 notification per day, on average, at one of four times. Notifications will be randomized on four dimensions of context. Exercise notifications are designed to encourage participants to exercise within their target heart rate zone. Notifications will be delivered each evening at a time of the participant's choosing. Participants will have a 50% probability of receiving a notification each evening. Notifications will be randomized on two dimensions of context. Participants will be followed for 6-months. Participants in both arms will be asked to complete a 6-minute walk test at baseline, 3-months, and 6-months using their mobile phone and smartwatch. They will additionally complete general and disease-specific quality-of-life questionnaires at baseline and at 6-months.

To account for potential measurement error between devices, for primary and secondary analyses, we will perform regression analysis to jointly test the null hypothesis H0: B0(F) = B0(A) = 0 for change between baseline and 6 months where (F) and (A) refer to Fitbit and Apple watches respectively. A secondary analysis will subsequently be performed to determine whether to reject the individual null hypotheses for each of the two devices. For all statistical analyses, the level of significance will be set at p <0.05.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 223
• Est. completion date: October 25, 2022
• Est. primary completion date: October 25, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion criteria:

1. Must be a patient within the Michigan Medicine clinical system with data available in the electronic health record after January 1, 2013. Spectrum Health patients may participate if they have a Michigan Medicine MRN and data is available through connected electronic health records.

2. Age > 18 and < 75

3. Owns an Android or iPhone with study supported operating software.

4. Understands English to enable informed consent, completion of study-related surveys, and compliance with study notifications.

5. Enrolled in cardiac rehabilitation within the past 8-weeks based on one of the following indications (listed below) and has completed at least 2 cardiac rehabilitation sessions (includes orientation session; to remain in the study, participants in the hybrid program must complete at least one additional exercise session for a minimum of 2 center-based rehabilitation sessions):

• Coronary artery disease (including acute coronary syndromes and stable angina) following percutaneous coronary intervention (PCI)

• Coronary artery disease following coronary artery bypass surgery (CABG)]

• Valve repair or replacement (either surgical or percutaneous)

• Coronary artery disease or an acute coronary syndrome not requiring revascularization

Exclusion criteria:

1. Orthopedic or neurological condition limiting ability to actively engage in exercise training session

2. Greater than mild cognitive impairment

3. Wrist too large to wear a smartwatch comfortably. This will be assessed by asking participants "If they have ever had difficulty wearing a watch in the past due to the band being too small."

4. Currently receiving palliative care and/or in hospice care

5. Severe valvular stenosis or regurgitation

6. Unrevascularized left main coronary artery disease (> 50% obstruction on angiography) or proximal left anterior descending disease (>70% obstruction on angiography).

7. Exercise-induced ventricular tachycardia

8. Cardiac arrest within the prior 6 months

9. New York Heart Association (NYHA) class III or IV heart failure

10. Pulmonary arterial hypertension treated with inhaled or intravenous pulmonary hypertension-specific therapy

11. Ejection fraction <40%

12. Determined to be unsafe for participation in this program to augment cardiac rehabilitation as assessed by a clinical nurse or investigative team.

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Heart Diseases

Intervention

Behavioral:
• Telehealth
Participants will receive weekly activity summaries and tailored notifications about their activity and goal setting behaviors.
• Control
Participants will get usual care and wear a smartwatch.

Locations

Country	Name	City	State
United States	University of Michigan	Ann Arbor	Michigan
United States	Spectrum Health	Grand Rapids	Michigan

Sponsors (2)

Lead Sponsor	Collaborator
University of Michigan	Spectrum Health Hospitals

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Proximal outcome for activity notifications.	The proximal outcome for activity notifications will be average step count 1-hour after a notification measured by smartwatch.	1-hour after an activity notification, up to 6-months.
Other	Proximal outcome for exercise notifications.	The proximal outcome for exercise notifications will be exercise minutes the day after a notification, defined as the number of "fairly active" and "very active" minutes on smartwatch.	The day after an exercise notification, up to 6-months.
Other	All-cause mortality and Cardiovascular mortality	The event numbers will be added together	6-months
Other	All-cause mortality and Cardiovascular mortality	The event numbers will be added together	12-months
Other	Cardiovascular hospitalizations		6-months
Other	Cardiovascular hospitalizations		12-months
Other	Change in 6-minute walk distance	6-minute walk distance is determined by the 6-minute walk test recorded using a mobile phone paired with a smartwach and recorded in meters.	Baseline, 3-months
Other	Change in 6-minute walk distance, subgroup analysis	6-minute walk distance is determined by the 6-minute walk test recorded using a mobile phone paired with a smartwach and recorded in meters. Outcome measures will be stratified by type of cardiac rehabilitation, duration of cardiac rehabilitation, age, gender, baseline walk distance, and comfort with digital technology.	Baseline and 6-months
Other	Change in average step count, subgroup analysis	Change in average step count as determined by smartwatch. Baseline average is the average step count from the first 7 days of wearing the smartwatch. The 6-month average step count is the daily average step count over one week at 6-months. Outcome measures stratified by type of cardiac rehabilitation, age, gender, baseline walk distance, and comfort with digital technology.	Baseline and 6-months
Other	Subgroup analyses of micro-randomized notifications by notification type	Subgroup analyses will be performed to determine which notification types are most effective based on the following features: Loss versus gain framework; Emoji versus no emoji in message; Message personalized with name versus no name ; Message includes hyperlink to study dashboard versus no hyperlink; Message encourages an activity versus anti-sedentary behavior.	6-months
Primary	Change in 6-minute walk distance	6-minute walk distance is determined by the 6-minute walk test recorded using a mobile phone paired with a smartwach and recorded in meters.	Baseline, 6-months
Secondary	Change in average step count	Change in average step count as determined by smartwatch. Baseline average is the average step count from the first 7 days of wearing the smartwatch. The 6-month average step count is the daily average step count over one week at 6-months.	Baseline, 6-months